J2KBIO Co., Ltd. (KOSDAQ:420570)
11,210
-60 (-0.53%)
At close: May 28, 2025, 3:30 PM KST
J2KBIO Revenue
In the year 2024, J2KBIO had annual revenue of 33.13B KRW with 16.36% growth. J2KBIO had revenue of 6.76B in the quarter ending December 31, 2024, a decrease of -18.90%.
Revenue
33.13B
Revenue Growth
+16.36%
P/S Ratio
1.93
Revenue / Employee
592.51M
Employees
55
Market Cap
62.98B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.13B | 4.66B | 16.36% |
Dec 31, 2023 | 28.47B | 12.44B | 77.60% |
Dec 31, 2022 | 16.03B | 1.81B | 12.75% |
Dec 31, 2021 | 14.22B | 360.95M | 2.60% |
Dec 31, 2020 | 13.86B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hyundai Motor Company | 178.98T |
Hanwha Aerospace | 15.28T |
KB Financial Group | 14.93T |
Kia Corporation | 109.25T |